Drug Trial Radar · NCT00004978
An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy
Last checked: Nov 19, 2026Latest source record: Nov 5, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
4,150
Actual
Start
Mar 2000
Primary completion
Nov 2008
Study completion Nov 2008
Sponsor
- Sponsor type
- NIH
- Collaborators
- Chiron Corporation
- First posted
- Aug 31, 2001
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to see if it is effective to give HIV positive patients recombinant interleukin-2 (rIL-2) in addition to anti-HIV therapy. Patients will be followed over a minimum of 4 years to study the long-term effects of rIL-2 on their HIV disease progression. Anti-HIV therapy has been very successful in treating HIV positive patients and in keeping viral load (level of HIV in the blood) low. However, anti-HIV drugs cannot completely rid the body of the virus, and the immune system is never completely restored in HIV positive patients. Doctors hope that giving patients recombinant interleukin-2 (rIL-2) in addition to their anti-HIV therapy will help improve their immune systems and keep them healthier over a longer period of time. rIL-2 is a hormone naturally produced by the body during an immune response to a microbial infection.
Conditions
- HIV Infections
Interventions
Recombinant interleukin-2 (rIL-2)Drug
Recombinant interleukin-2 at a dose of 7.5 MIU given twice daily subcutaneously for 5 consecutive days every 8 weeks for at least 3 cycles.
Primary outcomes
What the sponsor says the trial is designed to measure.
- New or Recurrent HIV Disease Progression Event Including DeathTime frame: from randomization through study end - median of 7.6 years follow-up
Locations
248 sites in 25 countries. Site status is shown where the registry gives one.
VA Greater Los Angeles Healthcare System, Infectious Diseases Section CRS
Los Angeles, California
Dr. M. Estes Med. Practice CRS
Mill Valley, California
Dr. Robert Scott Med. Practice CRS
Oakland, California
East Bay AIDS Ctr. CRS
Oakland, California
Dr. Shawn Hassler Med. Practice CRS
San Francisco, California
Positive Health Program Clinic (San Francisco Gen. Hosp.) CRS
San Francisco, California
Positive Health Practice West/ Dr. Steve Deeks CRS
San Francisco, California
Dr. William Owen Med. Practice CRS
San Francisco, California
Dr. Martin Mass Med. Practice CRS
San Francisco, California
San Francisco VAMC, Infectious Diseases Clinic CRS
San Francisco, California
UCSF PHP, Gen. Internal Medicine Practice CRS
San Francisco, California
Castro-Mission Health Ctr. CRS
San Francisco, California
Dr. Virginia Cafaro Med. Practice CRS
San Francisco, California
Denver Infectious Diseases Consultants CRS
Denver, Colorado
Denver Public Health CRS
Denver, Colorado
Univ. of Colorado Health Science Ctr. CRS
Denver, Colorado
Whitman-Walker Clinic CRS
Washington D.C., District of Columbia
George Washington Univ. Med. Ctr. Infectious Diseases - Clinical Trials Unit CRS
Washington D.C., District of Columbia
Walter Reed Army Med. Ctr., Infectious Disease Clinic CRS
Washington D.C., District of Columbia
Washington DC VAMC, Washington Regional AIDS Program, Infectious Diseases CRS
Washington D.C., District of Columbia
Dr. Timothy A. Price Med. Practice CRS
Washington D.C., District of Columbia
Miami VAMC CRS
Miami, Florida
Univ. of Miami, Infectious Diseases Clinical Research Unit CRS
Miami, Florida
ARCA, Central Clinc CRS
Atlanta, Georgia
Emory Univ. Crawford Long Hosp. CRS
Atlanta, Georgia
Atlanta VAMC CRS
Decatur, Georgia
Klein & Slotten Medical Associates CRS
Chicago, Illinois
Jesse Brown VAMC CRS
Chicago, Illinois
Univ. of Illinois Family Ctr. for Infectious Disease CRS
Chicago, Illinois
Lakeshore Infectious Disease Associates CRS
Chicago, Illinois
North Side Family Medicine CRS
Chicago, Illinois
Northwestern Memorial Physicians Group CRS
Chicago, Illinois
Med. Ctr. of Louisiana at New Orleans, HIV Outpatient Clinics CRS
New Orleans, Louisiana
Tulane University Health Sciences Center, Louisiana Community AIDS Research Program(LaCARP) CRS
New Orleans, Louisiana
New Orleans VAMC CRS
New Orleans, Louisiana
NIH Clinical Ctr., NIAID HIV Clinic CRS
Bethesda, Maryland
National Naval Med. Ctr., Infectious Diseases Special Immunology Clinic CRS
Bethesda, Maryland
Henry Ford Hosp. CRS
Detroit, Michigan
Wayne State Univ. CRS
Detroit, Michigan
St. John Hosp. & Med. Ctr., Infectious Diseases Dept. CRS
Grosse Pointe Woods, Michigan
Showing 40 of 248 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.